By JBizNews Desk
June 2, 2026
The neighborhood Walgreens that many Americans have relied on for prescriptions, over-the-counter medicines, and everyday essentials is undergoing one of the biggest transformations in its history.
Under its new private-equity owner, Walgreens Boots Alliance is accelerating store closures, eliminating hundreds of jobs, and restructuring major parts of its business as it pursues a dramatic turnaround plan aimed at restoring profitability.
According to state labor filings in Illinois and Texas, Walgreens is cutting at least 628 jobs, including 469 positions at corporate offices in Deerfield and Chicago and another 159 jobs tied to the closure of a Houston-area distribution center. The reductions took effect June 1 and represent the latest stage of a broader restructuring effort that has been unfolding for more than a year.
The cuts come after private-equity firm Sycamore Partners completed its roughly $10 billion acquisition of Walgreens in 2025, ending nearly a century as a publicly traded company.
The new owners have made their objective clear.
According to reports, Sycamore aims to double Walgreens’ earnings over the next several years, increasing profitability from roughly $2 billion annually to approximately $4 billion. Achieving that goal requires aggressive cost-cutting, operational changes, and a significant reduction in underperforming locations.
For customers, the most visible impact will be store closures.
Walgreens had already begun shutting down locations before the acquisition. Former CEO Tim Wentworth announced plans in 2024 to close approximately 1,200 underperforming stores over three years after acknowledging that the company’s existing footprint had become unsustainable.
More than 500 stores had already closed by early 2026.
Since taking control, Sycamore has accelerated that strategy, focusing resources on locations that generate stronger financial returns while eliminating stores that consistently lose money.
The result is a leaner Walgreens—but also a smaller one.
For many communities, particularly urban neighborhoods and lower-income areas, the closures raise concerns about growing “pharmacy deserts” where residents must travel farther to access medications and healthcare services.
Healthcare advocates warn that millions of Americans already live in areas with limited pharmacy access, and additional closures could worsen the problem.
The issue is particularly significant for seniors, patients with chronic conditions, and individuals without reliable transportation.
For those customers, the closure of a nearby pharmacy can mean more than inconvenience—it can affect healthcare outcomes.
Behind the scenes, Walgreens is also dismantling parts of the broader healthcare empire it spent years assembling.
The company has reorganized itself into several separate operating units, including its U.S. retail business, the Boots pharmacy chain in the United Kingdom, Shields Health Solutions, CareCentrix, and VillageMD.
Industry analysts expect some of those businesses could eventually be sold or spun off entirely.
The company is increasingly focusing on what management sees as its core strength: pharmacy operations.
One key component of that strategy is automation.
Walgreens has expanded the use of centralized fulfillment centers that can process prescriptions more efficiently than individual stores. Company officials say these facilities now handle a significant percentage of prescription volume, allowing pharmacists to spend more time with patients while reducing labor costs.
The broader challenges facing Walgreens are not unique.
Drugstore chains across the country have struggled with shrinking profit margins, reimbursement pressures from pharmacy benefit managers, rising theft, changing consumer behavior, and growing competition from online retailers.
The traditional drugstore model has come under increasing strain.
Rite Aid entered liquidation proceedings in 2025, while CVS Health has increasingly focused on healthcare services and insurance operations rather than relying solely on retail pharmacy sales.
The era when neighborhood drugstores generated substantial profits from front-of-store purchases such as cosmetics, snacks, seasonal merchandise, and convenience items has largely faded.
Inflation and changing shopping habits have pushed consumers to spend more cautiously.
For Walgreens employees, the restructuring creates uncertainty.
Workers at surviving stores often face increased responsibilities as staffing levels are reduced and operations become more centralized. Corporate employees face ongoing concerns about future rounds of restructuring.
For investors and management, however, the strategy is designed to create a company that is smaller but financially stronger.
Whether that goal can be achieved without further weakening customer loyalty remains one of the biggest questions facing the company.
For consumers, the practical reality is already becoming visible.
Fewer stores. Fewer employees. More automation.
The Walgreens of the future will likely look very different from the one that dominated American street corners for decades.
The challenge for the company is ensuring that efficiency gains do not come at the expense of the community presence that helped make Walgreens one of the most recognizable names in retail healthcare.
Retail & Healthcare — JBizNews Desk
© JBizNews.com All Rights Reserved. Reproduction or distribution without written permission is prohibited.
